SLI-381 (Adderall XR).
- Published in:
- 2003
- By:
- Publication type:
- journal article
Works matching IS 11727047 AND DT 2003 AND VI 17 AND IP 9
Results: 10
1
2
Opinion and Evidence in Neurology and Psychiatry.
- Published in:
- CNS Drugs, 2003, v. 17, n. 9, p. 679
- By:
- Publication type:
- Article
3
SLI-381 (Adderall XR®): A Viewpoint by Paul J. Ambrosini.
- Published in:
- CNS Drugs, 2003, v. 17, n. 9, p. 676, doi. 10.2165/00023210-200317090-00008
- By:
- Publication type:
- Article
4
SLI-381 (Adderall XR®): A Viewpoint by Charlotte Johnston.
- Published in:
- CNS Drugs, 2003, v. 17, n. 9, p. 676, doi. 10.2165/00023210-200317090-00007
- By:
- Publication type:
- Article
5
SLI-381 (Adderall XR[sup ®]).
- Published in:
- CNS Drugs, 2003, v. 17, n. 9, p. 669, doi. 10.2165/00023210-200317090-00006
- By:
- Publication type:
- Article
6
Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet.
- Published in:
- 2003
- By:
- Publication type:
- journal article
7
The glutamatergic system and Alzheimer's disease: therapeutic implications.
- Published in:
- 2003
- By:
- Publication type:
- journal article
8
Antiepileptic drug-induced pharmacodynamic aggravation of seizures: does valproate have a lower potential?
- Published in:
- 2003
- By:
- Publication type:
- journal article
9
Pain in terminally ill patients: guidelines for pharmacological management.
- Published in:
- 2003
- By:
- Publication type:
- journal article
10
Total intravenous anaesthesia: is it worth the cost?
- Published in:
- 2003
- By:
- Publication type:
- journal article